Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST)
Marco FioreElena PalassiniElena FumagalliS. PilottiElena TamboriniSilvia StacchiottiElisabetta PennacchioliPaolo G. CasaliAlessandro Gronchi
Metrics
Citation History
Topics
Related Documents
Preoperative imatinib for locally advanced gastrointestinal stromal tumors (GIST): CONVERT trial.
Bruno dos Santos Vilhena Pereira
Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
Sumin TangYuan YinChaoyong ShenJiaju ChenXiaonan YinBo ZhangYuqin YaoJinliang YangZhi‐Xin Chen
Surgery of residual disease following imatinib mesylate in advanced gastrointestinal stromal tumors (GIST)
Alessandro GronchiMarco FioreRossella BertulliMaurizio ColecchiaElena TamboriniS. PilottiA. MessinaPaola CocoSilvia StacchiottiPaolo G. Casali
Neoadjuvant imatinib and organ preservation in locally advanced gastrointestinal stromal tumors (GIST)
Peter HohenbergerOluwole Solomon OladejiThomas LichtAntonia Dimitrakopoulou‐StraussJens JakobDaniel PinkMatthias SchwarzbachPhilip StröbelPeter ReichardtEva Wardelmann
Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience
Piotr RutkowskiAlessandro GronchiPeter HohenbergerSylvie BonvalotPatrick SchöffskiSebastian BauerElena FumagalliPaweł NyckowskiBuu-Phuc NguyenJ. Martijn KerstMarco FioreElżbieta BylinaMathias HoiczykAnnemieke CatsPaolo G. CasaliAxel Le CesneJürgen TreckmannEberhard StoeckleJohannes H.W. de WiltStefan SleijferR. TielenWinette van der GraafCornelis VerhoefFrits van Coevorden